Pharmaids Pharmaceuticals Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Equivalents	1.34	21.45	48.04	127.54	4.07
Short-Term Investments	-	-	-	33.05	-
Cash & Short-Term Investments	1.34	21.45	48.04	160.59	4.07
Cash Growth	-93.77%	-55.36%	-70.09%	3841.48%	103.44%
Accounts Receivable	34.29	31.28	26.79	20.54	13.39
Receivables	34.29	31.28	26.79	20.54	13.39
Inventory	4.11	121.84	35.91	-	8.88
Prepaid Expenses	-	4.02	1.57	-	-
Other Current Assets	70.18	44.48	23.01	2.02	0.34
Total Current Assets	109.91	223.07	135.32	183.16	26.68
Property, Plant & Equipment	286.18	491.8	384.59	21.06	4.81
Goodwill	314.17	314.17	314.17	-	-
Other Intangible Assets	-	5.45	5.45	-	-
Long-Term Accounts Receivable	-	-	-	-	14.16
Long-Term Deferred Tax Assets	122.78	105.03	66.68	27.08	3.56
Long-Term Deferred Charges	-	-	-	1.21	-
Other Long-Term Assets	39.58	59	7.21	0.85	61.92
Total Assets	872.62	1,199	913.41	245.85	111.12
Accounts Payable	27.8	163.21	51.18	18.83	23.06
Accrued Expenses	0.47	6.58	4.62	0.28	-
Short-Term Debt	-	40.57	11.53	-	-
Current Portion of Long-Term Debt	90.69	10.06	6.14	-	-
Current Portion of Leases	6.42	7.93	7.13	-	-
Current Income Taxes Payable	-	0.26	-	-	-
Other Current Liabilities	114.71	58.53	35.16	2.14	1.35
Total Current Liabilities	240.09	287.15	115.76	21.25	24.41
Long-Term Debt	118.44	301.84	35.85	-	-
Long-Term Leases	18.27	29.35	24.68	-	-
Pension & Post-Retirement Benefits	1.79	7.78	6.15	-	-
Other Long-Term Liabilities	18	22	26	-0	-
Total Liabilities	396.6	648.11	208.44	21.25	24.41
Common Stock	352.68	352.68	352.68	214.44	102.69
Additional Paid-In Capital	-	505.75	505.75	104.24	-
Retained Earnings	-	-266.77	-139.3	-98.89	-23.33
Comprehensive Income & Other	123.86	1.55	1.34	4.81	7.36
Total Common Equity	476.54	593.2	720.47	224.6	86.72
Minority Interest	-0.51	-42.79	-15.5	-	-
Shareholders' Equity	476.03	550.42	704.97	224.6	86.72
Total Liabilities & Equity	872.62	1,199	913.41	245.85	111.12
Total Debt	233.82	389.75	85.33	-	-
Net Cash (Debt)	-232.49	-368.3	-37.29	160.59	4.07
Net Cash Growth	-	-	-	3841.48%	103.44%
Net Cash Per Share	-6.57	-10.44	-1.64	12.45	0.40
Filing Date Shares Outstanding	35.47	35.27	35.27	21.49	10.31
Total Common Shares Outstanding	35.47	35.27	35.27	21.49	10.31
Working Capital	-130.18	-64.07	19.56	161.91	2.27
Book Value Per Share	13.43	16.82	20.43	10.45	8.41
Tangible Book Value	162.37	273.59	400.85	224.6	86.72
Tangible Book Value Per Share	4.58	7.76	11.37	10.45	8.41
Land	-	254.5	178.22	-	-
Buildings	-	7.72	6.08	-	-
Machinery	-	184.48	116.88	-	5.09
Construction In Progress	-	45.3	70.01	-	4.5